GreenLight Biosciences (GRNAW)
0.02
-0.00 (-0.99%)
At close: Jul 21, 2023, 4:10 PM
-0.99% (1D)
| Bid | n/a |
| Market Cap | 0 |
| Revenue (ttm) | 10.2M |
| Net Income (ttm) | -158.07M |
| EPS (ttm) | 0 |
| PE Ratio (ttm) | 0 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 550 |
| Avg. Volume (20D) | 0 |
| Open | 0.02 |
| Previous Close | 0.02 |
| Day's Range | 0.02 - 0.02 |
| 52-Week Range | 0.02 - 0.02 |
| Beta | 0.00 |
About GRNAW
GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in Medford, Massachusetts....
Industry Biotechnology
Sector Healthcare
IPO Date n/a
Employees 280
Stock Exchange NASDAQ
Ticker Symbol GRNAW